[1]
A. R. Issahaku and M. Soliman, “Camptothecin and its Analogues as Putative Bruton Tyrosine Kinase (BTK) Inhibitors in Cancer Therapy - Biophysical Simulations of Wild Type and C481S Mutation”, JCBT, vol. 1, no. 1, pp. 59–71, Jul. 2024.